Cancer treatment firm Mersana appoints new chairman Boyd Clarke
-
Last Update: 2020-07-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
cancer treatment company Mersana has announced the appointment of Boyd Clarke as chairman of the companyClark is a senior executivein biotechnology and pharmaceuticals, with more than 30 years of experienceDrJulie Olsson, President and CEO of Mersana, said, "
our development phase,Boyd brings diverse management experience and business expertise to Mersana in key areasHis skills complement our existing teamWe believewill play a significant roleinhis strategic leadership as we continue to improve our portfoliowe continue to improve"
over the past 11 years,Clark has served as chairman and chief executive of several listed biotech companies, most recently with Neose Technologies"Mersana's Fleximer(
R) technology has the potential to create safer,more effective cancer drugs
the future of this technology is now being reflected in their clinical studies." I am very excited about the future of the company! As chairman,I look forward to participating in its continued development"
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
